| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.18 | 0.0002 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.16 | 0.0007 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.2 | 0.001 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.091 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.066 | 0.2 |